Technical Analysis for BIOC - Biocept, Inc.

Grade Last Price % Change Price Change
grade B 1.24 9.73% 0.11
BIOC closed up 9.73 percent on Friday, May 24, 2019, on 2.47 times normal volume.
14 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical BIOC trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
New Uptrend Bullish 9.73%
Calm After Storm Range Contraction 9.73%
Upper Bollinger Band Walk Strength 9.73%
Wide Bands Range Expansion 9.73%
Down 3 Days in a Row Weakness 9.73%
Gapped Down Weakness 9.73%

Older signals for BIOC ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:
Profile
Biocept, Inc., a cancer diagnostics company, is engaged in the development and commercialization of proprietary circulating tumor cell (CTC) and circulating tumor DNA tests. The company's tests provide information to oncologists that enable them to select the appropriate treatment for their patients based on detailed data on the characteristics of tumors. Its tests include OncoCEE-BR, a breast cancer CTC test that allows physician to characterize the tumor to help define treatment options. The company sells its products through its sales force and partners that focus on selling directly to community oncologists in hospitals, cancer centers, and offices in the United States. Biocept, Inc. was founded in 1997 and is headquartered in San Diego, California.
Medicine Cancer Medical Specialties Clinical Medicine Oncology Tumor Tumors Anatomical Pathology
Is BIOC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 24 FL, TSS, CVCO and IMRN among midday movers
May 24 Aphria and Biocept among healthcare gainers; AAC Holdings and DelMar Pharmaceuticals among losers
May 24 BIOC, HIBB among premarket gainers
May 23 Ekso Bionics and Tonix Pharmaceuticals among healthcare gainers; T2 Biosystems and Biocept among losers
May 23 WB, NTAP and HRL among premarket losers
May 22 QCOM, PSTG and VFC among premarket losers
May 21 ARRY, DY, QD and DQ among notable midday movers
May 21 Arrowhead Pharmaceuticals and Array BioPharma among healthcare gainers; Mallinckrodt and Ocular Therapeutix among losers
May 21 FCEL, STM among premarket gainers
May 20 Biocept's stock soars on heavy volume after commercial launch of liquid biopsy test for lung cancer
See more BIOC news...
Indicators
Indicator Value
52 Week High 12.15
52 Week Low 0.66
Average Volume 4,659,837
200-Day Moving Average 1.7457
50-Day Moving Average 1.0415
20-Day Moving Average 1.0073
10-Day Moving Average 1.0963
Average True Range 0.1838
ADX 26.96
+DI 52.0401
-DI 19.3479
Chandelier Exit (Long, 3 ATRs ) 1.5586
Chandelier Exit (Short, 3 ATRs ) 1.3314
Upper Bollinger Band 1.4536
Lower Bollinger Band 0.561
Percent B (%b) 0.76
BandWidth 88.613124
MACD Line 0.0665
MACD Signal Line 0.0195
MACD Histogram 0.0469
Fundamentals Value
Market Cap 37.52 Million
Num Shares 30.3 Million
EPS -1.06
Price-to-Earnings (P/E) Ratio -1.17
Price-to-Sales 5.54
Price-to-Book 3.79
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.72
Resistance 3 (R3) 1.75 1.61 1.64
Resistance 2 (R2) 1.61 1.49 1.60 1.61
Resistance 1 (R1) 1.43 1.42 1.52 1.40 1.59
Pivot Point 1.29 1.29 1.34 1.28 1.29
Support 1 (S1) 1.11 1.17 1.20 1.08 0.89
Support 2 (S2) 0.97 1.10 0.96 0.87
Support 3 (S3) 0.79 0.97 0.84
Support 4 (S4) 0.76